GENERATE BIOMEDICINES
Generate Biomedicines is a biotechnological company focusing on creating breakthrough medicines.
GENERATE BIOMEDICINES
Industry:
Biotechnology Health Care Medical
Founded:
2018-01-01
Address:
Somerville, Massachusetts, United States
Country:
United States
Website Url:
http://www.generatebiomedicines.com
Total Employee:
11+
Status:
Active
Email Addresses:
info@generatebiomedicines.com
Total Funding:
420 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Nginx Microsoft Exchange Online Amazon Organization Schema
Similar Organizations
Akouos
Akouos is a biotechnology company focusing on restoring and preserving hearing.
Rakuten Medical
Rakuten Medical is a Bio-technology Company.
Shoreline Biosciences
Shoreline Biosciences is a biomedical company intended to establish immunotherapies for seriously ill patients.
Watchmaker Genomics
Watchmaker Genomics is a biotechnology company that focuses on breakthrough applications for reading, writing, and editing DNA.
Current Employees Featured
Founder
Investors List
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Series B - Generate Biomedicines
Morningside Venture Investments
Morningside Venture Investments investment in Series B - Generate Biomedicines
T. Rowe Price
T. Rowe Price investment in Series B - Generate Biomedicines
Altitude Life Science Ventures
Altitude Life Science Ventures investment in Series B - Generate Biomedicines
Alaska Permanent Fund
Alaska Permanent Fund investment in Series B - Generate Biomedicines
ARCH Venture Partners
ARCH Venture Partners investment in Series B - Generate Biomedicines
Abu Dhabi Investment Authority
Abu Dhabi Investment Authority investment in Series B - Generate Biomedicines
Flagship Pioneering
Flagship Pioneering investment in Series B - Generate Biomedicines
Flagship Pioneering
Flagship Pioneering investment in Venture Round - Generate Biomedicines
Key Employee Changes
| Date | New article |
|---|---|
| 2022-04-25 | Generate Biomedicines Expands Leadership Team With Addition of Sean Martin as Chief Legal Officer and General Counsel |
Official Site Inspections
http://www.generatebiomedicines.com Semrush global rank: 1.81 M Semrush visits lastest month: 12.63 K
- Host name: ec2-54-237-143-203.compute-1.amazonaws.com
- IP address: 54.237.143.203
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Generate Biomedicines"
About Us - Generate:Biomedicines
Generate Biomedicines is a new kind of therapeutics company—existing at the intersection of biology, machine learning, and biological engineering.See details»
Generate:Biomedicines - Wikipedia
Generate's research is centered on leveraging machine learning to program proteins for specific functions. Its platform is trained on extensive datasets comprising 160,000 protein structures and 190 million genetic sequences. This system identifies patterns linking protein sequence, structure, and function, which are then used to design new therapeutic proteins. The company's technology includes two core components: de novo protein generation, which al…See details»
What Do We Share as Generators?
Mar 3, 2023 Second, we all act as owners of the organization. We share an open, inclusive, and collaborative culture based on integrity, trust, and a passion for learning. Generators are driven by the desire to create a healthier world. I …See details»
Generate Biomedicines - Crunchbase Company Profile …
Contact Email info@ generatebiomedicines. com Generate Biomedicines is a biotechnological company focusing on creating breakthrough medicines. It pioneers in the field of Generative Biology, a revolutionary approach to drug …See details»
Generate:Biomedicines - LinkedIn
Generate:Biomedicines | 31,760 followers on LinkedIn. Pioneering generative biology to create breakthrough therapeutics. | Pioneering generative biology to create breakthrough therapeutics.See details»
Generate:Biomedicines - PitchBook
Publication ID Patent Title Status First Filing Date Technology (CPC) Citations; US-20240161864-A1: Diffusion model for generative protein design: PendingSee details»
Generate:Biomedicines Fortifies Leadership in Generative AI with ...
CAMBRIDGE, Mass., January 04, 2024--Generate:Biomedicines today announced key advancements across its clinical pipeline and generative AI platform, including its first patient …See details»
Generate:Biomedicines Fortifies Leadership in Generative AI with ...
Jan 4, 2024 Learn more about Generate:Biomedicines by visiting www.generatebiomedicines.com or by following the company on Twitter and LinkedIn. View …See details»
The Generate Platform - Generate:Biomedicines
The Generate Platform–which is a continuous loop to generate, build, measure, and learn–can drastically increase the speed at which therapeutics are identified and validated.See details»
Generate:Biomedicines Announces Multi-Target Collaboration with ...
Sep 24, 2024 “ Partnering with a world-leading drug discovery and development organization like Novartis allows us to broaden the use of our cutting ... Learn more at …See details»
Generate:Biomedicines Raises Largest Biotech Series C of 2023
Sep 14, 2023 Generate:Biomedicines has announced the largest Series C for a biotech company in 2023 at $273 million, raising $700 million since 2020.See details»
Generate Biomedicines Uses AI to Create Proteins That Have Never ...
Dec 1, 2022 Generate Biomedicines today published a preprint describing a breakthrough in protein science that unlocks the ability to generate novel proteins, atSee details»
Generate:Biomedicines | Generate:Biomedicines Announces First…
Nov 18, 2021 This financing will enable Generate:Biomedicines to advance and evolve the platform as well as rapidly scale the organization with top-tier scientific and computational …See details»
Generate:Biomedicines Announces Multi-Target Collaboration
Sep 24, 2024 Founded by Flagship Pioneering in 2018, Generate is a clinical-stage company leading a fundamental shift from drug discovery to drug generation. Learn more at …See details»
Four Years of Generate: The Leading Edge of a
Generatebiomedicines.com Four Years of Generate: The Leading Edge of a Revolution When Generate was founded four years ago, we promised a digital revolution in biology. Our plan …See details»
Generate Biomedicines Announces First External Equity Raise of …
Nov 18, 2021 CAMBRIDGE, Mass.--(BUSINESS WIRE)--Generate Biomedicines, whose machine learning-powered Generative Biology platform can rapidly invent new drugs across a …See details»
Four Years of Generate: The Leading Edge of a Revolution
Sep 21, 2022 We are building an organization that goes beyond conventional business models and pushes the limits of what can be done in this space. We stand on the leading edge of a …See details»
Novartis, Generate:Biomedicines Sign Up-to-$1B AI Protein Drug ...
Sep 24, 2024 Novartis will apply Generate:Biomedicines’ generative artificial intelligence (AI) platform to discover and develop protein therapeutics for multiple unspecified disease areas, …See details»
Generate:Biomedicines | Generate:Biomedicines Announces Multi …
Sep 24, 2024 Somerville, Mass., September 24, 2024 – Generate:Biomedicines (“Generate”) today announced a multi-target collaboration with Novartis (NYSE: NVS) to discover and …See details»